Effects of vitamin A deficiency and opioids on parvalbumin + interneurons in the hippocampus of the HIV-1 transgenic rat

Current HIV Research

Volumn 10, Issue 5, 2012, Pages 463-468

  Guo, Ming ^a   Bryant, Joseph ^a   Sultana, Shireen ^a   Jones, Odell ^a   Royal III, Walter ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CREB; Erk1 2 protein kinases; Gamma amino butyric acid; HIV 1; Opioids; Parvalbumin; Transgenic rat; Vitamin A

Indexed keywords

OPIATE; PARVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HIPPOCAMPAL CA1 REGION; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNEURON; NONHUMAN; PROTEIN EXPRESSION; RAT; RETINOL DEFICIENCY; STRESS;

ANIMALS; CA1 REGION, HIPPOCAMPAL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HIV-1; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MORPHINE; NARCOTICS; PARVALBUMINS; PREGNANCY; RATS; RATS, TRANSGENIC; RECEPTORS, OPIOID, MU; VIRAL PROTEINS; VITAMIN A DEFICIENCY;

EID: 84866334675     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016212802138715     Document Type: Article

References (35)

1. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 1998; 121(Pt 11): 2043-2052.
2. Benalal D, Bachrach U. Opiates and cultured neuroblastoma x glioma cells. Effect on cyclic AMP and polyamine levels and on ornithine decarboxylase and protein kinase activities. Biochem J 1985; 227: 389-395.
3. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001; 25: 1-27.
4. Boisse L, Gill MJ, Power C. HIV infection of the central nervous system: clinical features and neuropathogenesis. Neurol Clin 2008; 26: 799-819.
5. Byrd DA, Fellows RP, Morgello S, et al. Neurocognitive impact of substance use in HIV infection. J Acquir Immune Defic Syndr 2011; 58: 154-62.
6. Carman JA, Hayes CE. Abnormal regulation of IFN-gamma secretion in vitamin A deficiency. J Immunol 1991; 147: 1247-12452.
7. Chen K, Zhang X, Wei XP, Qu P, Liu YX, Li TY. Antioxidant vitamin status during pregnancy in relation to cognitive development in the first two years of life. Early Hum Dev 2009; 85: 421-427.
8. Cochran SM, Fujimura M, Morris BJ, Pratt JA. Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse 2002; 46: 206-214.
9. Forrester JE, Sztam KA. Micronutrients in HIV/AIDS: is there evidence to change the WHO 2003 recommendations? Am J Clin Nutr 2011; 94: 1683S-1689S.
10. Gerfen CR, Baimbridge KG, Miller JJ. The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci USA 1985; 82: 8780-8784.
11. Gibson JR, Beierlein M, Connors BW. Two networks of electrically coupled inhibitory neurons in neocortex. Nature 1999; 402: 75-79.
12. Hohmann P, Greene RS. Retinoid induced changes in cAMPdependent protein kinase activity detected by a new minigel assay. FEBS Lett 1990; 261: 81-84.
13. Irlam JH, Visser MM, Rollins NN, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst Rev 2010; (12): CD003650.
14. June HL, Tzeng Yang AR, Bryant JL, Jones O, Royal W, III. Vitamin A deficiency and behavioral and motor deficits in the human immunodeficiency virus type 1 transgenic rat. J Neurovirol 2009; 15: 380-389.
15. Keilhoff G, Becker A, Grecksch G, Wolf G, Bernstein HG. Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 2004; 126: 591-598.
16. Kinney JW, Davis CN, Tabarean I, Conti B, Bartfai T, Behrens MM. A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci 2006; 26: 1604-1615.
17. Klausberger T. GABAergic interneurons targeting dendrites of pyramidal cells in the CA1 area of the hippocampus. Eur J Neurosci 2009; 30: 947-957.
18. Kraft-Terry SD, Stothert AR, Buch S, Gendelman HE. HIV-1 neuroimmunity in the era of antiretroviral therapy. Neurobiol Dis 2010; 37: 542-548.
19. Lane MA, Bailey SJ. Role of retinoid signalling in the adult brain. Prog Neurobiol 2005; 75: 275-293.
20. Langford D, Adame A, Grigorian A, et al. Patterns of selective neuronal damage in methamphetamine-user AIDS patients. J Acquir Immune Defic Syndr 2003; 34: 467-474.
21. Maki PM, Cohen MH, Weber K, et al. Impairments in memory and hippocampal function in HIV-positive vs HIV-negative women: a preliminary study. Neurology 2009; 72: 1661-1668.
22. Peng J, Vigorito M, Liu X, Zhou D, Wu X, Chang SL. The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART. J Neuroimmunol 2010; 218: 94-101.
23. Potter JD, Dedman JR, Means AR. Ca2+-dependent regulation of cyclic-AMP phosphodiesterase by parvalbumin. J Biol Chem 1977; 252: 5609-5611.
24. Rao JS, Kim HW, Kellom M, et al. Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. J Neuroinflammation 2011; 8: 101.
25. Reid W, Sadowska M, Denaro F, et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 2001; 98: 9271-9276.
26. Royal W, III, Wang H, Jones O, Tran H, Bryant JL. A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat. J Neuroimmunol 2007; 185: 29-36.
27. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001; 56: 257-260.
28. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol 2002; 8: 136-142.
29. Semba RD, Graham NM, Caiaffa WT, Margolick JB, Clement L, Vlahov D. (1993). Increased mortality associated with vitamin A deficiency during human immunodeficiency virus type 1 infection. Arch Intern Med 153: 2149-2154.
30. Sharma SK, Nirenberg M, Klee WA. Morphine receptors as regulators of adenylate cyclase activity. Proc Natl Acad Sci USA 1975; 72: 590-4.
31. Sultana S, Li H, Puche A, Jones O, Bryant JL, Royal W. Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine. J Neurovirol 2010; 16: 33-40.
32. Traber J, Gullis R, Hamprecht B. Influence of opiates on the levels of adenosine 3':5'-cyclic monophosphate in neuroblastoma X glioma hybrid cells. Life Sci 1975; 16: 1863-1868.
33. Vigorito M, Lashomb AL, Chang SL. Spatial learning and memory in HIV-1 transgenic rats. J Neuroimmune Pharmacol 2007; 2: 319-328.
34. Wang X, Zhou Z, Yang C, Xu J, Yang J. Nuclear factor-kappaB is involved in the phenotype loss of parvalbumin-interneurons in vitro. Neuroreport 2011; 22: 264-268.
35. Word Health Organization (2011). GLOBAL HIV/AIDS RESPONSE - Epidemic update and health sector progress towards Universal Access. Progress Report 2011.